To study CRC-derived EVs, we selected three colon cancer cell lines, Caco-2, HTC116, and HT29, which differ in their dysregulated pathways and their mutational status of the KRAS and BRAF genes. The gene discussed is KRAS; the disease is colorectal carcinoma.